| 赵雪谦,刘云启,陈 志,潘立平.miRNA-26a靶向调控GSK-3β参与Wnt/β-catenin信号通路调节IgA肾病肾纤维化[J].,2017,17(22):4232-4238 |
| miRNA-26a靶向调控GSK-3β参与Wnt/β-catenin信号通路调节IgA肾病肾纤维化 |
| MicroRNA-26a Participation the wnt/β-catenin Signaling Pathway Induced Renal Fibrosis by Target GSK-3β in IgA Nephropathy |
| 投稿时间：2016-11-28 修订日期：2016-12-25 |
| DOI：10.13241/j.cnki.pmb.2017.22.007 |
| 中文关键词: IgA肾病 miRNA-26a Wnt/β-catenin信号通路 |
| 英文关键词: IgA nephropathy MicroRNA-26a Wnt/β-catenin signaling pathway |
| 基金项目: |
|
| 摘要点击次数: 272 |
| 全文下载次数: 86 |
| 中文摘要: |
| 摘要 目的：通过检测IgA肾病不同程度肾间质纤维化患者肾组织miRNA-26a、β-catenin、GSK-3β、α-SMA的表达，探究miRNA-26a通过靶向调控GSK-3β参与Wnt/β-catenin信号通路所致肾间质纤维化。方法：根据肾间质纤维化程度将46例IgA患者分为实验组（轻度组、中度组、重度组），对照组为7例肾脏肿瘤远离肿瘤组织的正常肾组织。采用RT-qPCR方法检测各实验组及正常对照组共53例IgA肾病患者肾组织miRNA-26a的表达水平，分析miRNA-26a与IgA肾病肾纤维化的关系。分别采用RT-qPCR技术及免疫组化技术检测各组肾组织β-catenin、GSK-3β、α-SMAmRNA及蛋白的表达水平，各组之间进行比较，并与miRNA-26a进行相关性分析。结果：（1）与正常对照组相比，IgA 肾病患者肾活检组织miRNA-26a呈低表达，且随着肾间质病变程度加重，miRNA-26a表达水平显著降低，各组间差异具有统计学意义（P＜0.05）；（2）与正常对照组比较，IgA肾病患者肾组织GSK-3β、β-catenin、α-SMAmRNA和蛋白的表达升高，且表达程度随着肾间质病变程度加重逐渐增强，各组间比较差异具有统计学意义（P＜0.05）；（3）相关性分析：肾组织miRNA-26a与肾间质纤维化程度呈负相关（r=-0.943，P＜0.05），肾间质及肾小管GSK-3β、β-catenin、α-SMA的表达强度与肾间质纤维化程度正相关（r =0.917，P＜0.05；r =0.943，P＜0.05；r =0.926，P＜0.05），肾间质GSK-3β与β-catenin蛋白表达正相关（r=0.834，P＜0.05）。结论：miRNA-26a可通过靶向调控GSK-3β参与Wnt/β-catenin信号通路肾间质纤维化。 |
| 英文摘要: |
| ABSTRACT Objective: Through detecting miRNA-26a, β-catenin, GSK-3β and α-SMA expressions in IgA nephropathy with varying degrees of renal interstitial fibrosis, the study was performed to explore the effect of miRNA-26a targeting GSK-3β on Wnt/β-catenin signal pathway simulated renal interstitial fibrosis. Methods: Incorporated 46 cases of IgA nephropathy patients were divided into three group based on the degree of renal interstitial fibrosis, namely, mild group, moderate group and severe group; 7 cases of normal renal tissues away from the renal tumor tissues were selected as the control group. Expression levels of miRNA-26a in renal tissues of each group were detected based on RT-qPCR method, to analyze the correlation between miRNA-26a and renal fibrosis in patients with IgA nephropathy. Furthermore, mRNA and protein expression levels of β-catenin, GSK-3β and α-SMA in renal tissues were measured using RT-qPCR and immunohistochemistry, respectively, the comparison was then made in each group; subsequently, correlation analysis was further conducted to investigate the relationship of miRNA-26a with β-catenin, GSK-3β and α-SMA. Results: (1) Compared with the control group, miRNA-26a expression was down-regulated from renal biopsy of IgA nephropathy patients, the expression level of miRNA-26a was significantly decreased, showing statistical differences among groups (P<0.05). (2) Compared with the control group, mRNA and protein expression levels of β-catenin, GSK-3β and α-SMA in renal tissues were all increased in IgA nephropathy patients, and the degree of expression increased gradually with the increase of the degree of renal interstitial lesion, differences were statistically significant among groups (P<0.05). (3) Correlation analysis results indicated that there were negative correlation between miRNA-26a expression in renal tissues and the degree of renal interstitial fibrosis, differences were statistically significant among groups（r= -0.943, P＜0.05）, at the same time, expression intensities of GSK-3β, β-catenin and α-SMA in renal interstitium and renal tubules were positively correlated with the degree of renal interstitial fibrosis（r =0.917, P＜0.05; r =0.943, P＜0.05; r =0.926, P＜0.05）, meanwhile, positive correlation was also found regarding protein expression of GSK-3β and β-catenin in renal interstitium（r=0.834, P＜0.05）. Conclusion: Collectively, miRNA-26a can be involved in Wnt/β-catenin signal pathway simulated renal interstitial fibrosis via the regulation of GSK-3β. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
|
|
|
